Organization Overview
Alternative names
autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine (1 trial)
autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine (1 trial)
Breast Neoplasms (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Fibrosarcoma (Phase 2)
Gastrointestinal Hemorrhage (Phase 4)
Gastrointestinal Stromal Tumors (Phase 2)
Gaucher Disease (Phase 2)
Hemorrhage (Phase 4)
Histiocytic Sarcoma (Phase 2)
Histiocytoma, Malignant Fibrous (Phase 2)
Hodgkin Disease (Phase 3)
Leiomyosarcoma (Phase 2)
Liposarcoma (Phase 2)
Liposarcoma, Myxoid (Phase 2)
Lung Neoplasms (Phase 2)
Lymphangiosarcoma (Phase 2)
Lymphoma (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Melanoma (Phase 2)
Multiple Myeloma (Phase 3)
Myosarcoma (Phase 2)
Neoplasms, Plasma Cell (Phase 3)
Nerve Sheath Neoplasms (Phase 2)
Neuroendocrine Tumors (Phase 2)
Neurofibrosarcoma (Phase 2)
Plasmacytoma (Phase 2)
Proctitis (Phase 4)
Rhabdomyosarcoma (Phase 2)
Sarcoma (Phase 2)
Sarcoma, Synovial (Phase 2)